| Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial JA Ajani, KA Winter, LL Gunderson, J Pedersen, AB Benson, CR Thomas, ... Jama 299 (16), 1914-1921, 2008 | 955 | 2008 |
| Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 M Roach III, M DeSilvio, C Lawton, V Uhl, M Machtay, MJ Seider, ... Journal of Clinical Oncology 21 (10), 1904-1911, 2003 | 758 | 2003 |
| Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles JJ Nuyttens, PF Rust, CR Thomas Jr, AT Turrisi III Cancer 88 (7), 1517-1523, 2000 | 683 | 2000 |
| Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving … LL Gunderson, KA Winter, JA Ajani, JE Pedersen, J Moughan, ... Journal of clinical oncology 30 (35), 4344-4351, 2012 | 582 | 2012 |
| An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13 … CA Lawton, M DeSilvio, M Roach III, V Uhl, R Kirsch, M Seider, M Rotman, ... International Journal of Radiation Oncology* Biology* Physics 69 (3), 646-655, 2007 | 571 | 2007 |
| Melatonin: from basic research to cancer treatment clinics Vijayalaxmi, CR Thomas Jr, RJ Reiter, TS Herman Journal of Clinical Oncology 20 (10), 2575-2601, 2002 | 482* | 2002 |
| Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi … J Garcia-Aguilar, LA Renfro, OS Chow, Q Shi, XW Carrero, PB Lynn, ... The lancet oncology 16 (15), 1537-1546, 2015 | 432 | 2015 |
| Melatonin as a radioprotective agent: a review RJ Reiter, DX Tan, TS Herman, CR Thomas Jr International Journal of Radiation Oncology* Biology* Physics 59 (3), 639-653, 2004 | 420 | 2004 |
| SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and … E Ben-Josef, KA Guthrie, AB El-Khoueiry, CL Corless, MM Zalupski, ... Journal of Clinical Oncology 33 (24), 2617-2622, 2015 | 409 | 2015 |
| Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma AJ Grossberg, LC Chu, CR Deig, EK Fishman, WL Hwang, A Maitra, ... CA: a cancer journal for clinicians 70 (5), 375-403, 2020 | 369 | 2020 |
| A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial J Garcia-Aguilar, Q Shi, CR Thomas, E Chan, P Cataldo, J Marcet, ... Annals of surgical oncology 19, 384-391, 2012 | 348 | 2012 |
| Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial PJ Loehrer Sr, M Jiroutek, S Aisner, J Aisner, M Green, CR Thomas Jr, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 257 | 2001 |
| Artificial intelligence in radiation oncology: a specialty-wide disruptive transformation? RF Thompson, G Valdes, CD Fuller, CM Carpenter, O Morin, S Aneja, ... Radiotherapy and Oncology 129 (3), 421-426, 2018 | 244 | 2018 |
| Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer SJ Wang, A Lemieux, J Kalpathy-Cramer, CB Ord, GV Walker, CD Fuller, ... Journal of Clinical Oncology 29 (35), 4627-4632, 2011 | 244 | 2011 |
| Thymic carcinoma: state of the art review TY Eng, CD Fuller, J Jagirdar, Y Bains, CR Thomas Jr International Journal of Radiation Oncology* Biology* Physics 59 (3), 654-664, 2004 | 222 | 2004 |
| Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial M Roach, J Moughan, CAF Lawton, AP Dicker, KL Zeitzer, EM Gore, ... The lancet oncology 19 (11), 1504-1515, 2018 | 221 | 2018 |
| Whole-pelvis,“mini-pelvis,” or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology … M Roach III, M DeSilvio, R Valicenti, D Grignon, SO Asbell, C Lawton, ... International Journal of Radiation Oncology* Biology* Physics 66 (3), 647-653, 2006 | 220 | 2006 |
| Gender differences in publication productivity, academic position, career duration, and funding among US academic radiation oncology faculty EB Holliday, R Jagsi, LD Wilson, M Choi, CR Thomas Jr, CD Fuller Academic Medicine 89 (5), 767-773, 2014 | 210 | 2014 |
| The renal expression of transforming growth factor-β isoforms and their receptors in acute and chronic experimental diabetes in rats C Hill, A Flyvbjerg, H Grønbaek, J Petrik, DJ Hill, CR Thomas, ... Endocrinology 141 (3), 1196-1208, 2000 | 191 | 2000 |
| Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98‐11) JA Ajani, KA Winter, LL Gunderson, J Pedersen, AB Benson III, ... Cancer 116 (17), 4007-4013, 2010 | 183 | 2010 |
Emma HollidayThe University of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
